Record status This record was last updated September 19, 2024 (before its estimated December 2024 completion). Its status may not reflect the trial's current state.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Track this trialSee every version on ClinicalTrials.gov ↗
| NCT Number | NCT03154346 |
| Lead Sponsor | Baseline Study LLC
Collaborators: Verily Life Sciences LLC, Duke University, Stanford University, Google LLC. |
| Conditions (from sponsor) |
All |
| Related terms | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| Enrollment | 10,000 participants |
| Start Date | |
| Primary Completion | (estimated) |
| Study Completion | (estimated) |
| Updated on ClinicalTrials.gov |